Joint Formulary

The North Staffordshire Joint Formulary (NSJF) has been developed jointly between North Staffordshire CCG, Stoke-on-Trent CCG, University Hospital of North Staffordshire NHS Trust and North Staffordshire Combined Healthcare NHS Trust. It is applicable to all prescribers working within primary care or hospitals across North Staffordshire and Stoke-on-Trent. 

The main aim of the Joint Formulary is to promote safe, effective and economic prescribing in both general practice and hospital. Use of the Joint Formulary will also help to ensure seamless prescribing for patients between Primary and Secondary Care, thereby reducing the confusion and possible errors that can happen when medications are changed.

For more information about Joint Formulary, please see the pdf Formulary Introduction 2018 (359 KB)

Joint Formulary Documents

Information and recommendations presented have been produced following consultation with local specialists and primary care colleagues and with others who have a particular interest and/or knowledge in specific areas of therapeutics.

Each section of the Joint Formulary has been approved by the North Staffordshire and Stoke-on-Trent Area Prescribing Committee. The Joint Formulary is an evolving and dynamic document and it is regularly reviewed and updated.

The PDF version of the North Staffordshire Joint formulary has now been updated to netFormulary, a web-based platform. This is now available online at www.northstaffordshirejointformulary.nhs.uk Should you require any further support, please contact the Medicines Optimisation team on: This email address is being protected from spambots. You need JavaScript enabled to view it.

Additional Guidance Documents

 Continence Prescribing Formulary 2016 V2

The aim of this formulary is to identify the most appropriate use of catheters, sheaths, drainage bags and associated appliances for use in the community. It is expected that the majority of patients can be managed with the products recommended. This formulary provides guidance to  prescribers for appropriate product choices for the majority of patients and is not intended to restrict patient choice.

 Wound Care Formulary July 2016 V2

In 2010 The Department of Health instructed the National Prescribing Centre (NPC) to produce guidance on the purchasing and prescribing of dressings. An expert focus group was established which looked into ensuring quality and productivity for patient care. The guiding principles considered the whole patient care pathway, rather than focusing solely on the products being prescribed.

With this guidance Staffordshire and Stoke on Trent Partnership Trust (SSOTP) Tissue Viability Service (TVS) have developed a robust, evidenced based and concise Wound Care Formulary.

The formulary is designed to support nurses in their decision making process in the area of wound care. The formulary will be subject to review and a mechanism for comments and the assessment of new products will be ongoing. Any products which are identified as like for like, after going through a robust evaluation process and agreed with respective partners will be changed over if cost savings can be identified.

 Symptom Management in Palliative Care Patients

Drugs for the management of restlessness, nausea, vomiting, respiratory tract secretions and pain. (Jan 2013)

 Antimicrobial Guidelines 2016
The 2016 version supersedes any previous edition of the antimicrobial prescribing guidelines that were last issued in 2014. All previous copies of the guidelines either orange, red or blue booklets should no longer be used.